Covid-19 All Centre Update for w/c 18th May 2020
To help UK NEQAS participants in the current Covid-19 (Coronavirus) outbreak, we will be providing a weekly all-centre update. We will also provide an email address for each centre should anyone wish to make direct contact with their centre. Here’s the update for week commencing 18th May 2020:
|UK NEQAS Centre||Update for w/c 18th May 2020|
|Birmingham Quality (Clinical Chemistry)||Birmingham Quality will be open as usual this week and the on-line Schedule remains valid - email: email@example.com|
|Blood Coagulation||Awaiting centre update - email: firstname.lastname@example.org|
|Blood Transfusion Laboratory Practice||email: email@example.com|
|Cardiac Markers||Operating as normal. Distribution 265 for June will be back to scheduled distribution date but will keep under review - email: firstname.lastname@example.org
Information can be found on the UK NEQAS Cardiac Markers website www.ukneqas-cm.org.uk.
|Cellular Pathology Technique||Awaiting centre update - email: email@example.com|
|Edinburgh Peptide Hormones||Awaiting centre update - email: firstname.lastname@example.org|
|Genomics (GenQA)||Suitable COVID-19 Care Home Swabbing to ensure an accurate test result.
GenQA has provided an online tool for care home workers to improve the success of the swab test. It was launched on 11th May 2020, is quick and easy to use and follows on from the NHS training video.
Within one week, it has been used by 726 care homes across England and 1,550 assessments have been completed.
GenQA is also currently reviewing the timetable for 2020-21 and modifying the format of certain EQAs in recognition of the current changes within genomic laboratories. Full details will be available over the next few weeks.
- email: email@example.com
|Guildford Peptide Hormones||UK NEQAS Guildford Peptides are still operating a normal service - email: firstname.lastname@example.org|
|Haematology||UK NEQAS Haematology is open as usual but operating to a slightly amended schedule for June, as published on our website. Some reports have been delayed as we have allowed participants as much time as possible to return their results.
We would be grateful if participants could continue to email email@example.com rather than phone, where possible.
|Head and Neck Pathology||Awaiting centre update - email: firstname.lastname@example.org|
|Histocompatibility & Immunogenetics||Participants are now invited to complete their annual re-registration on the H&I online portal. Distributions for the 2020-21 year will commence on 2nd June - email: email@example.com|
|Immunocytochemistry & In-Situ Hybridisation||UK NEQAS ICC & ISH are continuing the preparatory work for dispatch of Run 130/59, which is expected to be sent out at the end of June. (Deadlines for laboratories will be re-aligned accordingly). ICC&ISH Staff members are working from home when possible, and only a few members of staff in work at one time for activities that cannot be carried out at home - email: firstname.lastname@example.org|
|Immunology, Immunochemistry & Allergy||Awaiting centre update - email: email@example.com|
|Leucocyte Immunophenotyping||No change, running all services as planned but with home working where possible and limited staff on site - email: firstname.lastname@example.org|
|Microbiology||Awaiting centre update - email: email@example.com|
|Parasitology||Parasitology is planning to resume distributions, starting in the first week of July 2020 - email: firstname.lastname@example.org|
|Reproductive Science||Reproductive Science is continuing as scheduled for now. Their next distribution is May and they intend extending the deadline from 4 weeks to 8 weeks. Result entry is now open for Andrology - Sperm Concentration & Morphology, Distribution 105. Due to the Covid-19 pandemic, Reproductive Science have extended the deadline for Distribution 105 by an extra four weeks to Monday 29th June, although participants are urged to complete the assessment as soon as they are able to do so - email: email@example.com|
|Trace Elements||UK NEQAS Trace Elements are still operating a normal service - email: firstname.lastname@example.org|
|UK National BNS Neuropathology Interpretative EQA Scheme||Awaiting centre update - email: email@example.com|
|Vitamin K||Running as normal. Will continue to monitor response rates to see if extensions are necessary - email: firstname.lastname@example.org|